The HPV vaccine is our first line of defense against HPV-associated malignancies. In order to curb HPV-related cancer rates, we must increase access to the vaccine for all genders, and improve uptake to ensure its efficacy. Hundreds of thousands of people across the globe face daily struggles in multiple aspects of their lives due to HPV and the diseases it causes . Worldwide, over 600,000 people are diagnosed with an HPV-related cancer every year and HPV results in a median of 137 cases of anogenital warts per 100,000 males and 120.5 per 100,000 females every year. In the US alone, around 360,000 people get genital warts every year, and in the UK there are around 86,800 new cases annually. The vaccine provides the opportunity for millions more to be protected against facing similar complications.

We already hold the tool to save these lives. We have committed ourselves to eradicating the HPV virus and its associated diseases, and support access to cancer prevention through immunization and screening.

To improve access to the vaccine, we have:

  • Testified before the FDA in support of expanding the Gardasil vaccine’s approval for anal cancer prevention for males and females. The FDA approved Gardasil for the prevention of anal cancer in December 2010.
  • Formed and led a coalition of 12 organizations to submit multiple joint testimonies to the CDC’s Advisory Committee on Immunization Practices (ACIP) to promote HPV vaccination in males. In October 2011, the CDC voted in favor of routine HPV vaccination for males.
  • Conducted extensive work in the UK through the joint coalition we helped found, HPVAction. HPVAction has:
  1. Started a petition for gender-neutral vaccination in the UK.
  2. Appeared on television to explain and promote the importance of vaccinating boys.
  3. Submitted in-person and written testimony to the UK’s Joint Committee on Vaccination and Immunisation (JCVI) regarding the importance of vaccinating all boys against HPV.
  • Testified before the New York Council’s Committees on Health and Women’s Issues about the need for improved education and awareness surrounding the vaccine amongst the medical and parent communities.
  • Lobbied for universal HPV vaccination through participating in extreme endurance races across the world through our NOMAN is an Island campaign.